BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17212326)

  • 1. [Diabetes and myocardial infarction: intensive glucose control important according to international guidelines].
    Norhammar A; Malmberg K; Mellbin L; Rydén L
    Lakartidningen; 2006 Nov 22-28; 103(47):3734, 3737-8; discussion 3738-9. PubMed ID: 17212326
    [No Abstract]   [Full Text] [Related]  

  • 2. [High blood glucose in diabetics a risk factor in acute myocardial infarction. Intensive insulin therapy--an interesting but not functioning idea].
    Dellborg M; Svensson AM
    Lakartidningen; 2006 Sep 13-19; 103(37):2624-5. PubMed ID: 17022181
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of insulin-glucose infusion on mortality following acute myocardial infarction in patients with diabetes: the diabetes and insulin-glucose infusion in acute myocardial infarction studies.
    Malmberg K; Rydén L
    Semin Thorac Cardiovasc Surg; 2006; 18(4):326-9. PubMed ID: 17395029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Critical evaluation of a "therapeutic study"].
    Praxis (Bern 1994); 1997 Oct; 86(41):1603-7. PubMed ID: 9417581
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.
    Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L;
    Eur Heart J; 2008 Jan; 29(2):166-76. PubMed ID: 18156614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefits of insulin therapy following acute myocardial infarction revisited.
    Soran H; Barzangy B; Younis N
    QJM; 2006 Sep; 99(9):635-7. PubMed ID: 16921196
    [No Abstract]   [Full Text] [Related]  

  • 7. Opinion: Tight blood glucose control and cardiovascular disease in the elderly diabetic? Let the randomized controlled trials speak for themselves.
    Sherman FT
    Geriatrics; 2008 Aug; 63(8):8-10. PubMed ID: 18672951
    [No Abstract]   [Full Text] [Related]  

  • 8. [Insulin in the diabetic heart patient, only the glycemic results count].
    Fredenrich A
    Soins; 2006 Mar; (703 Suppl 1):1S18-20. PubMed ID: 16604812
    [No Abstract]   [Full Text] [Related]  

  • 9. [Focus on intensive therapeutic strategy in type 2-diabetes].
    Mogensen CE
    Ugeskr Laeger; 1998 Sep; 160(38):5469-70. PubMed ID: 9763916
    [No Abstract]   [Full Text] [Related]  

  • 10. Intensive insulin treatment of diabetic patients with myocardial infarction is highly cost-effective.
    Hildebrandt P
    Eur Heart J; 2000 May; 21(9):700-2. PubMed ID: 10739721
    [No Abstract]   [Full Text] [Related]  

  • 11. Self-monitoring of blood glucose in patients with diabetes who do not use insulin--are guidelines evidence-based?
    Aakre KM; Watine J; Bunting PS; Sandberg S; Oosterhuis WP
    Diabet Med; 2012 Oct; 29(10):1226-36. PubMed ID: 22435892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence and prognostic significance of pathological glucose metabolism in acute myocardial infarction].
    Egstrup M; Henriksen FL; Høfsten DE; Hangaard J; Egstrup K
    Ugeskr Laeger; 2008 Mar; 170(11):940-2. PubMed ID: 18397621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood glucose quickly under control in diabetes mellitus 2].
    Wentholt IM; de Vries JH; Holleman F; Hoekstra JB
    Ned Tijdschr Geneeskd; 2009 Feb; 153(9):376-7. PubMed ID: 19348090
    [No Abstract]   [Full Text] [Related]  

  • 14. Leptin: a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes.
    Wallander M; Söderberg S; Norhammar A
    Diabet Med; 2008 Aug; 25(8):949-55. PubMed ID: 18959608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiating insulin in patients with type 2 diabetes.
    Aoki TJ; White RD
    J Fam Pract; 2007 Aug; 56(8 Suppl Hot Topics):S12-20. PubMed ID: 18667139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of inhaled insulin in the treatment of type 2 diabetes.
    Davis SN
    J Diabetes Complications; 2008; 22(6):420-9. PubMed ID: 18413196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does intensive glycemic control improve cardiovascular outcomes?
    Pendergrass M
    Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):529. PubMed ID: 18806805
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials.
    Bazzano LA; Lee LJ; Shi L; Reynolds K; Jackson JA; Fonseca V
    Diabet Med; 2008 Aug; 25(8):924-32. PubMed ID: 18959605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes--treat early, treat intensively.
    Goldstein BJ; Gomis R; Lee HK; Leiter LA;
    Int J Clin Pract Suppl; 2007 Dec; (157):16-21. PubMed ID: 17991187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
    Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.